Serous Adenocarcinoma — Trials

Serous Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

210 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 85
Recruiting: 35
Ph III recruiting: 6
Growth YoY: —
Industry share: 22%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (24)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07764744	Ovarian Cancer Liquid Biopsy for Early Assessment & Detection in Individuals With BRCA1/2 Pathogenic Variants(OC-LEAD)	not yet recruiting	N/A	70	Weill Medical College of Cornell UniversityOTHER	1	Sep 11, 2026	clinicaltrials
NCT07268469	Minimal Residual Disease in Solid Malignancies(IMRD)	not yet recruiting	N/A	840	European Institute of OncologyOTHER	0	Dec 5, 2025